We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$58.1B
AUM Growth
+$5.28B
Cap. Flow
+$1.06B
Cap. Flow %
1.82%
Top 10 Hldgs %
14.06%
Holding
4,799
New
857
Increased
1,497
Reduced
1,529
Closed
854

Sector Composition

Rank Sector Weight
1 Technology 8.49%
2 Consumer Discretionary 6.34%
3 Healthcare 4.58%
4 Financials 4.54%
5 Industrials 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AG icon
3726
First Majestic Silver
AG
$8.05B
$132K ﹤0.01%
22,415
-9,822
-30% -$49.2K
NFBK
3727
DELISTED
Northfield Bancorp
NFBK
$132K ﹤0.01%
13,553
-6,992
-34% -$76.7K
MCBC
3728
DELISTED
Macatawa Bank Corp
MCBC
$131K ﹤0.01%
+13,378
New +$137K
WRAP icon
3729
CALL
Wrap Technologies
WRAP
$94.8M
$131K ﹤0.01%
+57,900
New +$195K
ZVRA icon
3730
Zevra Therapeutics
ZVRA
$563M
$130K ﹤0.01%
22,332
-776
-3% -$4.77K
AMPX icon
3731
Amprius Technologies
AMPX
$1.31B
$129K ﹤0.01%
+48,629
New +$181K
SERA icon
3732
Sera Prognostics
SERA
$80.3M
$128K ﹤0.01%
+14,119
New +$112K
HTZ icon
3733
CALL
Hertz
HTZ
$572M
$128K ﹤0.01%
+16,300
New +$133K
HTZ icon
3734
PUT
Hertz
HTZ
$572M
$128K ﹤0.01%
+16,300
New +$133K
HAIN icon
3735
Hain Celestial
HAIN
$47.8M
$128K ﹤0.01%
16,235
-23,810
-59% -$235K
RPTX
3736
DELISTED
Repare Therapeutics
RPTX
$127K ﹤0.01%
27,058
-27,429
-50% -$176K
IAUX
3737
i-80 Gold Corp
IAUX
$1.17B
$127K ﹤0.01%
+94,798
New +$137K
NAGE
3738
Niagen Bioscience
NAGE
$256M
$127K ﹤0.01%
36,461
-25,438
-41% -$47.1K
IDN icon
3739
Intellicheck
IDN
$73.5M
$125K ﹤0.01%
36,003
-3,218
-8% -$6.18K
ALDX icon
3740
Aldeyra Therapeutics
ALDX
$91.7M
$125K ﹤0.01%
38,193
-34,771
-48% -$114K
LTBR icon
3741
Lightbridge
LTBR
$246M
$125K ﹤0.01%
42,292
+30,328
+253% +$92K
PUMP icon
3742
ProPetro Holding
PUMP
$1.45B
$124K ﹤0.01%
15,333
-28,531
-65% -$223K
HMY icon
3743
Harmony Gold Mining
HMY
$9.92B
$123K ﹤0.01%
15,101
-88,078
-85% -$562K
ULBI icon
3744
Ultralife
ULBI
$88.3M
$122K ﹤0.01%
+13,898
New +$113K
NNOX icon
3745
CALL
Nano X Imaging
NNOX
$62.4M
$122K ﹤0.01%
+12,500
New +$100K
SMMT icon
3746
Summit Therapeutics
SMMT
$10.9B
$122K ﹤0.01%
+29,450
New +$117K
NVNO
3747
enVVeno Medical
NVNO
$6.94M
$122K ﹤0.01%
+640
New +$115K
ONDS icon
3748
Ondas Inc
ONDS
$4.44B
$122K ﹤0.01%
+125,450
New +$165K
CDXS icon
3749
Codexis
CDXS
$135M
$122K ﹤0.01%
34,867
-70,894
-67% -$223K
VCSA
3750
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$122K ﹤0.01%
17,832
-10,817
-38% -$88.2K

Similar funds

Squarepoint's Q1 2024 Portfolio in Review

As of Q1 2024, Squarepoint held 4,799 positions worth $58.1B, up 10% from $52.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Squarepoint's Q1 2024 filing shows 857 new, 1,497 increased, 1,529 reduced and 854 closed positions. Its largest new stake was The Gap Inc: 3,316,943 shares worth $91.4M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.17B.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 9.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Squarepoint's largest Q1 2024 buy was The Gap Inc: 3,316,943 shares worth $91.4M.
  • Squarepoint added most to iShares Core S&P 500 ETF in Q1 2024, an estimated $701M increase.
  • Squarepoint's biggest Q1 2024 reduction was Invesco QQQ Trust, cutting an estimated $240M.
  • Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $1.17B.
  • Squarepoint's ten largest holdings make up 14% of its $58.1B portfolio in Q1 2024.
  • Squarepoint opened 857 new positions and closed 854 in Q1 2024.
  • Squarepoint's portfolio value rose 10% quarter-over-quarter to $58.1B.

Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.